CK Life Sciences Intl (Holdings) Inc Relative Valuation - CK Life Sciences Intl (Holdings) Inc - Alpha Spread

CK Life Sciences Intl (Holdings) Inc
HKEX:775

Watchlist Manager
CK Life Sciences Intl (Holdings) Inc Logo
CK Life Sciences Intl (Holdings) Inc
HKEX:775
Watchlist
Price: 0.36 HKD 1.41% Market Closed
Market Cap: 3.5B HKD
Have any thoughts about
CK Life Sciences Intl (Holdings) Inc?
Write Note

Relative Value

The Relative Value of one CK Life Sciences Intl (Holdings) Inc stock under the Base Case scenario is 0.83 HKD. Compared to the current market price of 0.36 HKD, CK Life Sciences Intl (Holdings) Inc is Undervalued by 57%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
0.83 HKD
Undervaluation 57%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
87
vs Industry
90
Median 3Y
1.3
Median 5Y
1.3
Industry
7.8
vs History
vs Industry
1
Median 3Y
54.9
Median 5Y
56.1
Industry
23.7
vs History
93
vs Industry
13
Median 3Y
15.5
Median 5Y
15.7
Industry
22.3
vs History
84
vs Industry
3
Median 3Y
17.2
Median 5Y
20.3
Industry
24.8
vs History
84
vs Industry
65
Median 3Y
1.5
Median 5Y
1.6
Industry
2.5
vs History
93
vs Industry
74
Median 3Y
1.9
Median 5Y
2
Industry
7.6
vs History
93
vs Industry
57
Median 3Y
6.1
Median 5Y
6.2
Industry
8.8
vs History
55
vs Industry
8
Median 3Y
20.8
Median 5Y
21
Industry
4.8
vs History
85
vs Industry
4
Median 3Y
36.7
Median 5Y
36
Industry
4.5
vs History
93
vs Industry
10
Median 3Y
25
Median 5Y
25.5
Industry
6.4
vs History
93
vs Industry
5
Median 3Y
40.4
Median 5Y
40.4
Industry
4.4
vs History
93
vs Industry
62
Median 3Y
1
Median 5Y
1
Industry
4.8

Multiples Across Competitors

Competitors Multiples
CK Life Sciences Intl (Holdings) Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
HK
CK Life Sciences Intl (Holdings) Inc
HKEX:775
3.5B HKD 0.6 -185.4 20.5 20.5
US
Abbvie Inc
NYSE:ABBV
341.7B USD 6.2 64.5 15.8 24.1
US
Amgen Inc
NASDAQ:AMGN
181.2B USD 5.9 57.9 20.2 36.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
126.5B USD 9.4 29.3 25.7 28.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120B USD 11.6 -245 26 27.3
US
Epizyme Inc
F:EPE
94.1B EUR 1 981.8 -505.7 -550.7 -536
US
Gilead Sciences Inc
NASDAQ:GILD
103.6B USD 3.7 98.4 9.4 11.9
AU
CSL Ltd
ASX:CSL
141.9B AUD 6.5 36.6 22.4 27.9
US
Seagen Inc
F:SGT
39.3B EUR 19.1 -58.5 -63 -56.9
US
Palatin Technologies Inc
LSE:0KF3
38.5B USD 6 513.5 -1 169.6 -1 185.3 -1 173.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
35.1B USD 15 -480.9 211.7 325.8
P/E Multiple
Earnings Growth
HK
CK Life Sciences Intl (Holdings) Inc
HKEX:775
Average P/E: 57.3
Negative Multiple: -185.4
N/A
US
Abbvie Inc
NYSE:ABBV
64.5
406%
US
Amgen Inc
NASDAQ:AMGN
57.9
74%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
29.3
56%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -245
38%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -505.7 N/A
US
Gilead Sciences Inc
NASDAQ:GILD
98.4
71%
AU
CSL Ltd
ASX:CSL
36.6
64%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.5 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 169.6 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -480.9 N/A

See Also

Discover More
Back to Top